Table 4.
Regimen | Patient number | Detection cancer, n (%) | Detection 10 mm+, n (%) | Detection 6–9 mm, n (%) | Detection 1–5 mm, n (%) | False positive 10 mm+, n | False positive 6–9 mm, n | False positive 1–5 mm, n | P valuea |
---|---|---|---|---|---|---|---|---|---|
A | 23 | 2/2 (100%) | 1/2 (50%) | N/A | 3/10 (30%) | 0 | 1 | 7 | 0.15 |
B | 23 | N/A | 3/3 (100%) | 5/6 (83%) | 10/30 (33%) | 0 | 1b | 9 | |
C | 23 | N/A | 1/1 (100%) | 2/2 (100%) | 6/20 (30%) | 0 | 0 | 1 | |
D | 20 | N/A | 3/3 (100%) | 2/4 (50%) | 4/12 (33%) | 1c | 1 | 2 | |
Overall | 89 | 2/2 (100%) | 8/9 (89%) | 9/12 (75%) | 23/72 (32%) | 1 | 3 | 19 |
N/A Not applicable
aComparison of false positives across regimens using one-way ANOVA
bIn patient with confirmed 8-mm polyp
cIn patient with confirmed 10-mm polyp